Identification of the Mechanism of Non-histaminergic Itch Inducing Epigenetic Changes
1 other identifier
interventional
30
1 country
1
Brief Summary
Itch is defined as an unpleasant sensation that evokes the desire to scratch. Chronic itch, defined as itch persisting for more that 6 weeks, is a key symptom in many diseases severely affects the quality of life of the affected patients and represents a substantial economic burden for the society. At present, there are no effective treatments for chronic itch diseases. Moreover, chronic itch patients express differences in their genes compared with people who do not suffer from itch. With this experiment, we wish to analyse differences in genes expression in healthy volunteers who have been exposed to artificial itch from small plant needles from the plant cowhage (mucuna pruriens) and compare them to controls who have not been exposed to itch.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2025
CompletedFirst Submitted
Initial submission to the registry
May 22, 2025
CompletedFirst Posted
Study publicly available on registry
May 31, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
June 4, 2025
May 1, 2025
1.6 years
May 22, 2025
May 30, 2025
Conditions
Outcome Measures
Primary Outcomes (8)
miRNA expression over time
Plasma miRNA evaluation
Before active/inactive cowhage
miRNA expression over time
Plasma miRNA evaluation
30 minutes post-Active/inactive cowhage
miRNA expression over time
Plasma miRNA evaluation
3 hours post-active/inactive cowhage
miRNA expression over time
Plasma miRNA evaluation
24 hours post-active/inactive cowhage
Protein expression over time
Plasma protein evaluation
Before active/inactive cowhage
Protein expression over time
Plasma protein evaluation
30 minutes post-active/inactive cowhage
Protein expression over time
Plasma protein evaluation
3 hours post-active/inactive cowhage
Protein expression over time
Plasma protein evaluation
24 hours post-active/inactive cowhage
Secondary Outcomes (2)
Assessment of itch: visual analog scale (VAS)
Immediately after Active/inactive cowhage
Assessment of pain: visual analog scale (VAS)
Immediately after Active/inactive cowhage
Study Arms (2)
Active cowhage
ACTIVE COMPARATORThe participant will receive active cowhage in the forearm.
Inactive cowhage
SHAM COMPARATORThe participant will receive inactive cowhage in the forearm.
Interventions
Whole blood samples (5 mL per each time point, a total of 20 mL per subject) will be collected
Eligibility Criteria
You may qualify if:
- Healthy men and women
- years
- Speak and understand English
You may not qualify if:
- Pregnancy or lactation
- Drug addiction defined as any use of cannabis, opioids, or other addictive drugs
- Previous or current history of neurological (e.g., neuropathy), immunological (e.g., asthma, immune deficiencies, arthritis) musculoskeletal (e.g., muscular pain in the upper extremities), cardiac disorder, or mental illnesses that may affect the results,
- Lack of ability to cooperate
- Current use of medications that may affect the trial such as antihistamines, antipsychotics, and pain killers, as well as systemic or topical steroids
- Allergy to lidocaine
- Skin diseases (e.g., atopic dermatitis, pruritus nodularis, eczema, psoriasis)
- Moles, scars, or tattoos in the area to be treated or tested.
- Consumption of alcohol or painkillers 24 hours before the study days and between these
- Smoking
- Acute or chronic pain
- Participation in other trials within one week of study entry (four weeks in the case of pharmaceutical trials)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aalborg University
Gistrup, 9260, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The participants are blinded about receiving active or inactive cowhage
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
May 22, 2025
First Posted
May 31, 2025
Study Start
May 15, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2027
Last Updated
June 4, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share